PMID: 3322375Dec 1, 1987Paper

Effects of subcutaneous oestradiol implants on ovarian activity

British Journal of Obstetrics and Gynaecology
A L MagosJ W Studd

Abstract

The effects of subcutaneous oestradiol implants on ovarian activity were investigated in 14 ovulating premenopausal women. Treatment with either 100 mg or 150 mg oestradiol was combined with cyclical oral norethisterone from days 20 to 26 of the cycle to ensure regular withdrawal periods and prevent endometrial hyperplasia. Ovarian function was monitored by regular pelvic ultrasonography and urinalysis over a period of nine cycles. During the first three cycles after hormone implantation, follicular development continued in almost half the study group, but only one of the women in each treatment group showed signs of follicular rupture and luteinization. By the sixth cycle, over half the women given the lower dose of oestradiol were developing follicles, including a large functional cyst in one, but none of them ovulated. A further implant given early in the seventh cycle was associated with ovarian suppression in all cases. Both doses of implant elevated the excretion of oestrone-3-glucuronide compared to pretreatment. The contraceptive and therapeutic implications of these results are discussed.

References

Jan 1, 1979·Journal of Biosocial Science. Supplement·R B GreenblattV P McNamara
Mar 1, 1977·American Journal of Obstetrics and Gynecology·R B GreenblattJ R Bryner
Mar 1, 1985·British Journal of Obstetrics and Gynaecology·J F WattsG Holder
Aug 1, 1974·Archives of Surgery·N P Rossi, C P Goplerud
Oct 1, 1982·Acta Endocrinologica·D A WeerasekeraH R Lindner
Nov 1, 1983·Journal of Neurology, Neurosurgery, and Psychiatry·A L MagosJ W Studd
Mar 22, 1980·British Medical Journal·M H Thom, J W Studd
Apr 1, 1981·British Journal of Obstetrics and Gynaecology·M H ThomJ W Studd
Mar 22, 1980·British Medical Journal·M E PatersonJ W Studd
Mar 5, 1981·The New England Journal of Medicine·E HirvonenV Manninen
Feb 1, 1981·British Journal of Obstetrics and Gynaecology·S LyrenäsB von Schoultz
Mar 1, 1953·Endocrinology·K J RYAN, L L ENGEL
Sep 1, 1954·American Journal of Obstetrics and Gynecology·R B GREENBLATTS L CLARK
Nov 9, 1963·British Medical Journal·I DONALD
Feb 1, 1949·American Journal of Obstetrics and Gynecology·R B GREENBLATT, R R SURAN

❮ Previous
Next ❯

Citations

Mar 1, 1993·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·F MartinezP N Barri
Jan 1, 1993·Baillière's Clinical Endocrinology and Metabolism·J W Studd, R N Smith
Oct 8, 1988·BMJ : British Medical Journal·N R WatsonM Savvas
Mar 11, 1989·BMJ : British Medical Journal·J Pemberton
Apr 1, 1996·Baillière's Clinical Obstetrics and Gynaecology·A Glasier, A Gebbie
Jan 1, 1988·Maturitas·M L'HermiteE Van Roosendaal
Nov 16, 2014·Post Reproductive Health·John Studd
Jun 1, 1995·British Journal of Obstetrics and Gynaecology·A Fiander
Jun 1, 1990·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·N R WatsonR J Baber

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.